Acumen Research and Consulting Atrial Fibrillation Drugs Market is Anticipated to | Page 19

15.5. Boehringer Ingelheim 15.5.1. Company Snapshot 15.5.2. Overview 15.5.3. Financial Overview 15.5.4. Product Portfolio 15.5.5. Key Developments 15.5.6. Strategies 15.6. Bristol-Myers Squibb 15.6.1. Company Snapshot 15.6.2. Overview 15.6.3. Financial Overview 15.6.4. Product Portfolio 15.6.5. Key Developments 15.6.6. Strategies 15.7. Daiichi Sankyo 15.7.1. Company Snapshot 15.7.2. Overview 15.7.3. Financial Overview 15.7.4. Product Portfolio 15.7.5. Key Developments 15.7.6. Strategies 15.8. AstraZeneca 15.8.1. Company Snapshot 15.8.2. Overview 15.8.3. Financial Overview 15.8.4. Product Portfolio Would like to place an order or any question, please feel free to contact at [email protected] | [phone]